# Takeda Pharmaceutical Company Limited – FDA Inspection, Nov 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/1a77ba55-396a-4912-81d2-ff91a8e53f0c
Source feed: FDA_Inspections

> FDA inspection 1293098 of Takeda Pharmaceutical Company Limited, November 26, 2025. 5 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293098
- Company Name: Takeda Pharmaceutical Company Limited
- Inspection Date: 2025-11-26
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Chicago District Office
- Citation Count: 5

## Related Documents

- FDA Inspection 1179911 - 2022-09-15
- [FDA Inspection 1103189 - 2019-09-25](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/f815b5da-2d6a-4e03-8688-006a8fbebf36)

## Related Officers

- [Investigator](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)
- [FDA Associated Person](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)

Company: https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669
